Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 11, 2007CancerOpen Access

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

Elias Jabbour
Elias JabbourLiechtenstein InstituteCHChitra HosingThe University of Texas MD Anderson Cancer CenterGAGregory D. AyersVanderbilt University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jabbour et al. (2007) studied this question.

synapsesocial.com/papers/6a1094afd478ddac0ffd3701https://doi.org/10.1002/cncr.22714
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.1997 · 159 citations
  2. 2Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group.1998 · 241 citations
  3. 3Residual mass in lymphoma may not be residual disease.1988 · 223 citations
  4. 4Hodgkin’s Lymphoma: Evolving Concepts with Implications for Practice2004 · 51 citations
  5. 5A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model2001 · 428 citations